title: Is the third generation EGFR TKIs the solution for making EGFR mutant NSCLC a curable disease?
authors: Division of Medical Oncology, Department of Medicine, University of Colorado Denver, Aurora, CO, USA.
authors: Fred R
authors: FR
authors: Hirsch